ATHIRA PHARMA INC. - COMMON STOCK
0.4443
27-九月-24 15:59:55
15 分钟延时
股票
+0.0257
+6.14%
今日范围
0.4250 - 0.4465
ISIN
N/A
来源
NASDAQ
-
06 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer
31 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Athira Pharma Provides 2023 Pipeline Outlook
05 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Athira Pharma Announces Publication of Fosgonimeton Preclinical Results in Neurotherapeutics
21 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
05 12月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Host Virtual R&D Event on December 7, 2022, from 2:00 –3:30 pm Eastern time
01 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
28 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
21 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
16 11月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
10 11月 2022 16:05:04 条件 Nasdaq GlobeNewswire
-
Athira Pharma to Present at Stifel 2022 Healthcare Conference
09 11月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
07 11月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
17 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
06 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
15 8月 2022 16:05:02 条件 Nasdaq GlobeNewswire
-
Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022
02 8月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
25 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire